IGM Biosciences Inc (IGMS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

325 E MIDDLEFIELD ROAD MOUNTAIN VIEW, CA 94043

IGM Biosciences, Inc. operates as a biotechnology company. The Company specializes in the research and development for the treatment of cancer. IGM Biosciences serves customers in the United States.

Data as of 2020-07-26
Market Cap1.642 Billion Shares Outstanding30.648 Million Avg 30-day Volume106.388 Thousand
P/E Ratio7.4 Dividend Yield EPS7.28
Price/Sales Price cash flow ratio Price free cash flow ratio-35.1
Book Value7.31 Price to Tangible Book7.33 Alpha
Short Interest Ratio % Short Interest to Float R-squared
BETA 52-week High/Low80.55 / 16.1 Stddev
View SEC Filings from IGMS instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 3 3 (0.2%)
13F Filers holding this stock: 60 22 (1.44%)
Aggregate 13F shares on 03/31/2020: 13.246 Million 9.767 Million
Aggregate 13F shares on 12/31/2019: 12.485 Million 8.971 Million
Percent change: 6.10% 8.87%
Funds creating new positions: 18 8
Funds Adding to an existing position: 15 5
Funds closing out their position: 10 4
Funds reducing their position: 18 4
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding IGMS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IGMS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

3 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

REDMILE GROUP, LLC

GREEN JEREMY

  • 10% Owner
0 2020-07-29 4

BAKER BROS. ADVISORS LP

667, L.P.

BAKER BROS. ADVISORS (GP) LLC

BAKER BROTHERS LIFE SCIENCES LP

BAKER FELIX

BAKER JULIAN

  • Director
0 2020-07-24 4

LEE MICHAEL STEWART

  • Director
356 2020-07-01 5

LOBERG MICHAEL D

  • Director
1,070 2020-07-01 6

BEHRENS M KATHLEEN

  • Director
83,214 2020-07-01 7

TOPSOE CHRISTINA TENG

  • Director
10,324,542 2020-07-01 7

TOPSOE JAKOB HALDOR

  • Director
10,344,224 2020-07-01 9

KEYT BRUCE CHIEF SCIENTIFIC OFFICER

  • Officer
6,533 2020-06-04 6

HAMBLETON JULIE

  • Director
0 2020-05-20 4

SCHWARZER FRED CEO AND PRESIDENT

  • Officer
  • Director
197,814 2020-05-15 3

NEU KELVIN

  • Director
0 2020-03-16 1

TAHIR MISBAH CHIEF FINANCIAL OFFICER

  • Officer
0 2020-02-05 2

STROHL WILLIAM

  • Director
0 2020-02-05 3

CHEN DANIEL SHINYU CHIEF MEDICAL OFFICER

  • Officer
0 2020-02-05 2

HALDOR TOPSOE HOLDING A/S

  • 10% Owner
10,289,453 2019-09-18 2

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

TOPSOE JAKOB HALDOR - Director

2020-07-01 A 178 a 54,771 10,344,224.00 direct

TOPSOE CHRISTINA TENG - Director

2020-07-01 A 357 a 35,089 10,324,542.00 direct

LEE MICHAEL STEWART - Director

2020-07-01 A 178 a 356 356.00 direct

BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

667, L.P. - Director - > 10% Owner see footnotes

BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

BAKER FELIX - Director - > 10% Owner see footnotes

BAKER JULIAN - Director - > 10% Owner see footnotes

2020-07-01 A 223 a 2,883,650 3,144,892.00 indirect

LOBERG MICHAEL D - Director

2020-07-01 A 535 a 535 1,070.00 direct

BEHRENS M KATHLEEN - Director

2020-07-01 A 357 a 63,214 83,214.00 direct

BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

667, L.P. - Director - > 10% Owner see footnotes

BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

BAKER FELIX - Director - > 10% Owner see footnotes

BAKER JULIAN - Director - > 10% Owner see footnotes

2020-07-01 A 223 a 261,242 3,144,892.00 indirect

REDMILE GROUP, LLC - Director - > 10% Owner see footnote

GREEN JEREMY - > 10% Owner see footnote

2020-07-01 A 178 a 3,144,356 3,144,356.00 indirect

KEYT BRUCE - Officer CHIEF SCIENTIFIC OFFICER see footnote

2020-06-04 M 2,837 $1.39 a 3,850 6,533.00 indirect

LOBERG MICHAEL D - Director

2020-06-04 G 535 d 0 1,070.00 direct

KEYT BRUCE - Officer CHIEF SCIENTIFIC OFFICER see footnote

2020-06-04 F 104 $58.40 d 3,896 6,533.00 indirect

KEYT BRUCE - Officer CHIEF SCIENTIFIC OFFICER see footnote

2020-06-04 M 150 d 2,250 6,533.00 indirect

KEYT BRUCE - Officer CHIEF SCIENTIFIC OFFICER see footnote

2020-06-04 M 150 $40.27 a 4,000 6,533.00 indirect

LOBERG MICHAEL D - Director see footnote

2020-06-04 G 535 a 535 1,070.00 indirect

KEYT BRUCE - Officer CHIEF SCIENTIFIC OFFICER see footnote

2020-06-04 M 2,837 d 6,242 6,533.00 indirect
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments